Invention Grant
- Patent Title: Hepatitis C virus inhibitors
-
Application No.: US14434210Application Date: 2012-10-19
-
Publication No.: US09499550B2Publication Date: 2016-11-22
- Inventor: Li-Qiang Sun , Eric Mull , Eric P. Gillis , Michael S. Bowsher , Qian Zhao , Kishore V. Renduchintala , Kandhasamy Sarkunam , Pulicharla Nagalakshmi , P.V.K. Suresh Babu , Paul Michael Scola
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- International Application: PCT/US2012/061094 WO 20121019
- International Announcement: WO2014/062196 WO 20140424
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00 ; A61K31/4725 ; A61K38/12 ; C07B59/00
Abstract:
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Public/Granted literature
- US20150284391A1 HEPATITIS C VIRUS INHIBITORS Public/Granted day:2015-10-08
Information query
